Drug Shortage Report for MYLAN-INDAPAMIDE
Report ID | 194 |
Drug Identification Number | 02153483 |
Brand name | MYLAN-INDAPAMIDE |
Common or Proper name | Indapamide |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | Indapamide |
Strength(s) | 2.5mg |
Dosage form(s) | Tablet |
Route of administration | Oral |
Packaging size | 100BT |
ATC code | C03BA |
ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2016-09-22 |
Estimated end date | |
Actual end date | 2017-03-29 |
Shortage status | Resolved |
Updated date | 2017-03-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-10 | English | Compare |
v2 | 2017-03-10 | French | Compare |
v3 | 2017-03-29 | English | Compare |
v4 | 2017-03-29 | French | Compare |
v5 | 2017-03-31 | English | Compare |
v6 | 2017-04-04 | English | Compare |
Showing 1 to 6 of 6